AcetaSTAT Validation and Commercialization

Project: Research project

Project Details

StatusActive
Effective start/end date4/1/24 → 3/31/26

Funding

  • ACETAMINOPHEN TOXICITY DIAGNOSTICS, LLC (3SB1DK079387-NWU AMD 1 // 3SB1DK079387)
  • National Institute of Diabetes and Digestive and Kidney Diseases (3SB1DK079387-NWU AMD 1 // 3SB1DK079387)